Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma

Overview of attention for article published in Molecular Cancer Therapeutics, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 8 tweets from 8 users, with an upper bound of 9,437 followers.

RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…

RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…

RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…

RT @philmw: Exciting cancer chemotherapy work published by my @UoN_Pharmacy colleague and collaborators at @DukeU Preclinical Testing…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 4 additional tweets.